Pharmaceutical Packaging Market Size to Worth Around USD 221.2 Bn by 2030
The Pharmaceutical Packaging market is projected to reach US$ 221.2 Bn by 2030. And registering a CAGR of around 11.4% over the forecast period 2021 – 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38615
Growth Factors
The growing prevalence of chronic diseases coupled with the growth of the pharmaceutical industry is anticipated to augment the consumption of pharmaceutical packaging products.
Growing penetration of retail pharmacies in developing regions and a rising focus on brand enhancement and product differentiation by pharmaceutical manufacturers are anticipated to drive market growth. Packaging products are primarily utilized for storing solid, liquid, and semisolid forms of formulations, such as tablets, capsules, syrups, and topical drug formulations. The increasing prevalence of chronic diseases due to changing lifestyles, eating habits, and alternation in sleep cycles are contributing to an increased need for medications
Report Coverage
| Report Scope | Details |
| Market Size | USD 221.2 billion by 2030 |
| Growth Rate | CAGR of 11.4% From 2021 to 2030 |
| Base Year | 2021 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Material, Product, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Amcor plc; Becton, Dickinson, and Company; AptarGroup, Inc.; Drug Plastics Group; Gerresheimer AG; Schott AG; Owens Illinois, Inc.; West Pharmaceutical Services, Inc.; Berry Global, Inc.; WestRock Company; SGD Pharma; International Paper; Comar, LLC; CCL Industries, Inc.; Vetter Pharma International |
Report Highlights
Plastics & polymers hold the greatest revenue share of 38.1% in 2020. Various types of plastic resins including PE, PET, PP, PVC, PS, and bioplastic are widely used for manufacturing pharmaceutical vials, bottles, closures, syringes, pouches, sachets, cartridges, tubes, and blister packs. Paper & paperboard are majorly used in secondary and tertiary packaging of pharmaceutical products. Excellent printability, low cost, wide availability, and sustainability of paper & paperboard make them lucrative secondary and tertiary packaging options.
Glass is impervious to gases, moisture, odors, and microorganisms, thus, is widely employed in the packaging of liquid and semisolid pharmaceutical formulations. Glass is used for manufacturing injectable vials, syrup bottles, cartridges, syringes, and other products. Aluminum is another commonly used material for pharmaceutical packaging. It is used as a lidding material in blister packs owing to its strong barrier and easy-to-tear properties.
The primary product segment lead for the largest revenue share of over 76.3% in 2020 and is likely to retain its leading position over the forecast period. Primary packaging, such as bottles, tubes, or blister packs, directly comes in contact with the drug and thereby envelopes the drug and protects it from contamination. Secondary pharmaceutical packaging is a consecutive covering or package, which stores several groups of pharmaceutical packages together and protecting the packages from external impacts.
Tertiary packaging is used for wrapping or packaging a set of products. The packaging is used for safe handling and smooth transportation of goods. Some of the examples of tertiary packaging include brown cardboard boxes, shrink-wraps, and plastic bags.
Pharma manufacturing is the key end-use segment that accounted for the highest share of 51.2% in 2020 and is expected to witness strong growth from 2021 to 2030. This is owing to the increasing demand for medicines.
Market players in the pharmaceutical industry have increased the outsourcing of packaging activities to save their expenses and time. Instead of investing in packaging products, manufacturers are outsourcing packaging operations to specialized and highly capable contractors to ensure efficient packaging. This is expected to push the demand for contract manufacturing.
Retail pharmacies are increasingly incorporating branding activities on their packaging to differentiate them from others. Polybags and paper pouches are the commonly used packaging products by such retail pharmacies. The increasing penetration of retail, especially in developing countries like India, China, and Brazil, is expected to boost the retail pharmacy end-use segment.
North America accounted the market with a revenue share of 38.1% in 2020, wherein pharma manufacturing, which includes in-house production, was the largest end-use segment in the region.
Asia Pacific is projected to register the fastest CAGR of more than 13% from 2021 to 2030. Growing health awareness among consumers in Asia Pacific, especially in developing countries including China and India, coupled with the rising disposable income levels is anticipated to boost the growth of the pharmaceutical industry over the forecast period augmenting demand for its packaging. Europe is expected to have considerable growth owing to the rising research & development activities and introduction of new medicines aimed at improving patient health and their quality of life.
Key Players
- Amcor plc
- Becton, Dickinson, and Company
- AptarGroup, Inc.
- Drug Plastics Group
- Gerresheimer AG
- Schott AG
- Owens Illinois, Inc.
- West Pharmaceutical Services, Inc.
- Berry Global, Inc.
- WestRock Company
- SGD Pharma
- International Paper
- Comar, LLC
- CCL Industries, Inc.
- Vetter Pharma International
Market Segmentation
- Material
- Plastics & Polymers
- Polyvinyl Chloride (PVC)
- Polypropylene (PP)
- PET
- PE
- PS
- Others
- Paper & Paperboard
- Glass
- Aluminum Foil
- Others
- Plastics & Polymers
- Product
- Primary
- Plastic Bottles
- Caps & Closures
- Parenteral Containers
- Blister Packs
- Prefillable Inhalers
- Pouches
- Medication Tubes
- Others
- Secondary
- Prescription Containers
- Pharmaceutical Packaging Accessories
- Tertiary
- Primary
- End-use
- Pharma Manufacturing
- Contract Packaging
- Retail Pharmacy
- Institutional Pharmacy
- Regional
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Turkey
- Asia Pacific
- China
- Japan
- India
- South Korea
- Central & South America
- Brazil
- Argentina
- Middle East & Africa (MEA)
- Egypt
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38615
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Pharmaceutical Packaging Market, By Material
7.1. Pharmaceutical Packaging Market, by Material, 2021-2030
7.1.1. Plastics & Polymers
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Paper & Paperboard
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Glass
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Aluminum Foil
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Pharmaceutical Packaging Market, By Product
8.1. Pharmaceutical Packaging Market, by Product, 2021-2030
8.1.1. Primary
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Secondary
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Tertiary
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmaceutical Packaging Market, By End User
9.1. Pharmaceutical Packaging Market, by End User, 2021-2030
9.1.1. Pharma Manufacturing
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Contract Packaging
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Retail Pharmacy
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Institutional Pharmacy
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmaceutical Packaging Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.2. Market Revenue and Forecast, by Product (2017-2030)
10.1.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Product (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Product (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.2. Market Revenue and Forecast, by Product (2017-2030)
10.2.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Product (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Product (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Product (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Product (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.2. Market Revenue and Forecast, by Product (2017-2030)
10.3.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Product (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Product (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Product (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.2. Market Revenue and Forecast, by Product (2017-2030)
10.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Product (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Product (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Product (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.2. Market Revenue and Forecast, by Product (2017-2030)
10.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Product (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Product (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. Amcor plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson, and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AptarGroup, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Drug Plastics Group
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Gerresheimer AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Schott AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Owens Illinois, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. West Pharmaceutical Services, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Berry Global, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. WestRock Company
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38615
Contact Us:
Vision Research Reports
Call: +1 9197 992 333